Stockscreener 앱 받기
23.35
0.55%
-0.13
시장 영업 전:
23.59
0.24
+1.03%
Pacira Biosciences Inc 주식(PCRX)의 최신 뉴스
Pacira shareholders lobbied by hedge fund board nominees - MSN
Trading the Move, Not the Narrative: (PCRX) Edition - Stock Traders Daily
PCRX Stock Chart | PACIRA BIOSCIENCES INC (NASDAQ:PCRX) - ChartMill
[DFAN14A] Pacira BioSciences, Inc. SEC Filing - Stock Titan
DOMA Perpetual Capital Issues a Press Release to Pacira BioSciences Shareholders - marketscreener.com
Doma Perpetual urges Pacira BioSciences shareholders to judge sale price adequacy - marketscreener.com
Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy - TradingView
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC - PR Newswire
DOMA Perpetual Issues a Press Release to Shareholders of Pacira BioSciences - marketscreener.com
PCRX: DOMA Capital Advocates for Change in Pacira BioSciences Bo - GuruFocus
DOMA Perpetual Director Nominees Send Letter to Shareholders of Pacira Biosciences - Nasdaq
Pacira Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Pacira BioSciences Issues Investor Presentation for Shareholders - marketscreener.com
Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders - The Manila Times
Pacira BioSciences Files Investor Presentation Highlighting - GlobeNewswire
Pacira Q1 earnings miss estimates on higher costs, revenues rise y/y - MSN
Do options traders know something about Pacira BioSciences stock we don't? - MSN
Pacira BioSciences: Exparel Still Supports My Original Bull Case (NASDAQ:PCRX) - Seeking Alpha
Pacira BioSciences, Inc.Common Stock (NQ: PCRX - The Chronicle-Journal
(PCRX) Volatility Zones as Tactical Triggers - Stock Traders Daily
Pacira BioSciences stock (US6951271005): Activist investor DOMA nominates three board directors - AD HOC NEWS
UBS Group AG Has $14.46 Million Position in Pacira BioSciences, Inc. $PCRX - MarketBeat
DOMA Perpetual Issues & Mails Letter to Shareholders of Pacira BioSciencesAlong with its Definitive Proxy Statement & WHITE Proxy CardUrging Shareholders to Vote "FOR" DOMA's Three Highly Qualified, Independent Board Candidates - Sahm
DOMA Perpetual nominates three directors to Pacira board By Investing.com - Investing.com India
Concerns Rise Over Pacira BioSciences' (PCRX) Board Management S - GuruFocus
Pacira BioSciences' (NASDAQ:PCRX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
DOMA Perpetual nominates three directors to Pacira board - Investing.com UK
Pacira BioSciences to Participate in Fireside Chats at Three Upcoming Healthcare Conferences - Yahoo Finance
Vanguard Group Inc. Sells 384,612 Shares of Pacira BioSciences, Inc. $PCRX - MarketBeat
DOMA Perpetual Capital Solicits Proxies from Shareholders of Pacira BioSciences - marketscreener.com
Pacira BioSciences sends letter to stockholders reiterating superior qualifications of its board nominees - marketscreener.com
Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees - TradingView
Activist DOMA (PCRX) Seeks CEO Removal, Board Seats; Pushes Sale Vote - Stock Titan
Pacira BioSciences Sends Letter to Stockholders Reiterating Superior Qualifications of its Board Nominees - GlobeNewswire
HC Wainwright Expects Lower Earnings for Pacira BioSciences - MarketBeat
Pacira Q1 2026 slides: EXPAREL growth accelerates, margins compress By Investing.com - Investing.com Australia
Earnings call transcript: Pacira BioSciences Q1 2026 earnings exceed forecasts - Investing.com UK
Earnings call transcript: Pacira BioSciences Q1 2026 earnings exceed forecasts By Investing.com - Investing.com Australia
Pacira BioSciences reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Pacira Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
10 new Pacira hires get stock options and restricted units - Stock Titan
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Pacira BioSciences Reports Strong Q1 2026 Results and Highlights Success of 5x30 Strategy, Urges Stockholders to Vote "FOR" Board Nominees - Quiver Quantitative
Pacira BioSciences Mails Letter to Stockholders - The Manila Times
PACIRA BIOSCIENCES INC (NASDAQ:PCRX): A Value Stock Candidate with Margin of Safety - ChartMill
Contact - FinancialContent
MSN Money - MSN
How Pacira’s Q1 2026 Results, EXPAREL Data and Proxy Battle May Impact Pacira BioSciences (PCRX) Investors - Sahm
Price-Driven Insight from (PCRX) for Rule-Based Strategy - Stock Traders Daily
Assessing Pacira BioSciences (PCRX) Valuation After Earnings Update And New EXPAREL Real World Data - Yahoo Finance
Pacira Biosciences Q1 Non-GAAP Earnings Fall, Revenue Rises; 2026 Sales Forecast Maintained - Moomoo
Universal Beteiligungs und Servicegesellschaft mbH Boosts Stock Position in Pacira BioSciences, Inc. $PCRX - MarketBeat
Pacira BioSciences Reports Strong First Quarter Growth for EXPAREL - HarianBasis.co
1.92%
4.44%
자본화:
|
볼륨(24시간):